Skip to main content

Animations

MJFF Publications

3531 - 3540 of 8620 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2020
  • 2024
  • 2025
  • 2024
  • 2022
  • 2022
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23179639
    Citation Count: 19
  • Summary Details
    OPEN
    Title: The emerging postural instability phenotype in idiopathic Parkinson disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00287-x
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Influence of species and processing parameters on recovery and content of brain tissue‐derived extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/20013078.2020.1785746
    Citation Count: 97
  • Summary Details
    OPEN
    Title: DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease
    Journal Name: GeroScience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11357-024-01116-0
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70028
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mdc3.14264
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Structure of the second phosphoubiquitin–binding site in parkin
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jbc.2022.102114
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29058
    Best OA location URL:
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28631
    Best OA location URL:
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.033
    Citation Count: 23
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.